By Nov. 1, MD Anderson's agreement with Blue Cross Blue Shield Medicare Advantage will expire, leaving patients on that plan ...
Blue Cross and Blue Shield of Texas announced it has made the decision to remove MD Anderson Cancer Center in Houston from ...
Blue Cross and Blue Shield of Texas said MDA will no longer be in its Medicare Advantage (PPO)SM or Blue Cross Medicare Advantage (HMO)SM as of Nov. 1, 2024.
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination ...
Researchers conducted a subgroup analysis of POSEIDON trial data, then characterized underlying biologic mechanisms using mouse models.
One of the many patients who left MD Anderson cancer free, Rachel Cruz Auwarter, is now paying it forward as one of the top ...
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Clinical trials of single-agent targeted drugs have shown limited efficacy. In the only trial of single-agent immunotherapy ...
A recent study delves into the subtle ways that tobacco and smoking use is being promoted on streaming platforms.